Screening HIV-infected patients with low CD4 counts for cryptococcal antigenemia prior to initiation of antiretroviral therapy: cost effectiveness of alternative screening strategies in South Africa

Bruce A. Larson, Peter C. Rockers, Rachael Bonawitz, Charlotte Sriruttan, Deborah K. Glencross, Naseem Cassim, Lindi M. Coetzee, Gregory S. Greene, Tom M. Chiller, Snigdha Vallabhaneni, Lawrence Long, Craig van Rensburg, Nelesh P. Govender

PLOS One. 2016 Jul;.

Thresholds for the cost–effectiveness of interventions: alternative approaches

Elliot Marseille, Bruce Larson, Dhruv S Kazi,James G Kahn, & Sydney Rosen

Bulletin of the World Health Organization. 2014 Dec; 1-16.

Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study

Callie A Scott, Hari S Iyer, Kelly McCoy, Crispin Moyo, Lawrence Long, Bruce A Larson, and Sydney Rosen

BMC Public Health. 2014 Mar; 14(296).

Effect of antiretroviral therapy on patients’ economic well-being: five-year follow up in South Africa

Sydney Rosen; Bruce Larson; Julia Rohr; Ian Sanne; Constance Mongwenyana; Alana T. Brennan; Omar Galárraga

AIDS. 2013 Sep;.

Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa

Gesine Meyer-Rath, Alana T. Brennan, Matthew P. Fox, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Sydney Rosen, and Neil Martinson

JAIDS. 2013 Jan; 62(3):322-328.

HE2RO Policy Brief 6: THE Benefits of Antiretroviral Therapy for Patients’ Economic Well-Being

Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galarraga O

2013 Jan.

Costs of Inpatient Treatment for Multi-Drug Resistant Tuberculosis in South Africa

Kathryn Schnippel, Sydney Rosen, Kate Shearer, Neil Martinson, Lawrence Long, Ian Sanne and Ebrahim Variava

Tropical Medicine and International Health. 2012 Dec;.

Per Diem Policy Analysis Toolkit

Taryn Vian and Lora Sabin

Norway: U4 Anti-Corruption Resource Centre; 2012 Dec.

Reply to Letter Regarding Validation Study of the Child Status Index: Do Not Shoot the Messenger

Lora Sabin, Maxton Tsoka, Mohamad I. Brooks, Jonathon Simon, Candace Miller

Journal of Acquired Immunity Deficiency Syndromes. 2012 Jun; 60(2):e69-e71.

Scaling up Xpert MTB⁄RIF technology: the costs of laboratory vs. clinic-based roll-out in South Africa

Kathryn Schnippel, Gesine Meyer-Rath, Lawrence Long, William MacLeod, Ian Sanne, Wendy S. Stevens and Sydney Rosen

Tropical Medicine and International Health. 2012 Jun; 00(00):1-10.

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen

PLoS ONE. 2012 May; 7(5):1-11.

How to calculate the annual costs of NGO- implemented programmes to support orphans and vulnerable children: a six-step approach

Bruce A Larson & Nancy Wambua

Journal of The International AIDS Society. 2012 Apr; 14(59):1-16.

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere PimaTM Analyzer in South Africa

Bruce Larson, Kathryn Schnippel, Buyiswa Ndibongo, Lawrence Long, Matthew P. Fox, & Sydney Rosen

PLoS ONE. 2012 Apr; 7(4):1-8.